Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. - Wikidata - awgldk - TriplyDB

Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

http://www.wikidata.org/entity/Q37878617

about

Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies Relation of C pneumoniae antibodies to ischaemic heart disease. Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies Infections and atherosclerosis.Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology.Antibiotics in the prevention and treatment of coronary heart disease.Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals Atherosclerosis: an infectious disease?Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays The probable role of cytomegalovirus in acute myocardial infarction.Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?Chronic infections and atherosclerosis/thrombosis.Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.Parachlamydiaceae: potential emerging pathogens The seroepidemiology of the chronic infections in patients with myocardial infarction in North of Iran.Evaluation of the level of antibodies against Chlamydophila (Chlamydia) pneumoniae in post-surgery heart ischaemia patients and their clinical conditions - a six-year study Chlamydophila pneumoniae infection and cardiovascular disease Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran.A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age.Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians: is there a link?Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.Antibodies to Chlamydia pneumoniae in young Swedish orienteers.Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae.Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.Description and status of the azithromycin and coronary events study (ACES).Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory Genitourinary chlamydial infection: a reappraisal and hypothesis.Chlamydia pneumoniae and Cardiovascular Disease.

P2860

Q24805877-222F9380-D4E3-4021-BDF9-27A11F371FE0 Q33355197-9DABF0AE-0F7C-4CE9-84A9-0910396998A6 Q33799285-E5E69214-EF4F-44E9-AA7D-E2762335B1D8 Q33889878-97FB2E47-49F7-466B-8734-AF31AEA0DB1F Q33905858-9A0168F8-35F4-46F0-A580-E0717A6ED687 Q33921219-1D361971-5BB3-4726-89E5-E8D55A020F4F Q33935019-64429C0A-D1F6-4A73-A4BC-DD2678D6F2D9 Q33935098-458DCF10-8C85-4B3C-AA42-A76CDAEFF7A2 Q33942966-33CBF432-30ED-4E5C-A476-1EED9B9E98DA Q33972282-39F45002-CE45-42B3-9A88-7D381953139E Q33972834-BE015A05-DD60-4AAD-BC2F-D55CECFF1434 Q33987842-4A572A53-794E-43AB-B91A-E943863E1816 Q33998574-BAAD76EA-9015-4A9E-87EA-9FE3D5FB70CB Q34068668-3A131DD4-8198-4959-8B57-0ADCF7320ACD Q34316462-891E972A-54AA-4B8E-A4C7-B191B7B4084D Q34514051-31443AF8-BD3F-4955-BB0C-741F05D5E99A Q34605079-F1A94F0A-BF38-4331-9724-A3956B283F3E Q34650053-CCEEBBF2-2FC9-4909-82A2-E29CFF76C2C6 Q34863840-DFB1E77E-2896-408B-AEFD-20417754640A Q35762026-C079D195-996C-48AD-A100-990896301A67 Q36783331-2654BACA-7149-4177-BDC7-5CA8DD742789 Q36822495-779E25D2-7F36-4FA4-A841-296641FD7BF8 Q37346172-A4CB29BD-951D-40EB-BFA9-5D98DA85E601 Q37865613-64F4E4F5-9AC8-4BCC-BFB9-C543ED424DF0 Q37868503-5401F7B0-E495-4204-B06E-45DADB916A50 Q37871352-A22CAC51-1472-4521-8B56-B6F8359F0879 Q37872308-C353CA07-1D59-4BD8-9D86-4C1D070C6276 Q37873576-86D18874-EB0F-4A5A-A274-BCF4B62C7FF2 Q37874634-E17F21BA-0C37-4D4A-B357-9D5D7ACAA1E7 Q37876040-86FB601F-5AA1-49FC-805B-F6BAB4C7E3F1 Q37876308-6F47FE3C-6E34-4D8E-91F8-DAD1BE376C08 Q39365197-EE6F114B-296D-4E07-B156-C3B79E34E814 Q43427569-1F4301DF-D04F-4B3C-9AEC-52B6FBC5BDE5 Q51726841-FF757615-134F-4BE6-B7EA-9EB39C38DCEC

P2860

Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

http://www.wikidata.org/entity/Q37878617

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 1999

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@en

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@nl

type

label

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@en

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@nl

prefLabel

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@en

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@nl

P1433

Q37878617-086CF17F-BF3D-4745-A5AE-D425F1701E6C

P1476

Q37878617-6F9E6C31-F2FB-4E0A-BDCD-88A9204242DB

P2093

Q37878617-022E2C9F-5660-4D21-85A4-9335231B6E41

Q37878617-3F58998B-1BFC-432C-BBCA-E1743E7959BF

Q37878617-6AED068D-9FD3-4BEA-9F5E-4D09D81BA1EA

Q37878617-71DDAA8D-B2F2-49DE-A195-1B5400FB9B8C

Q37878617-79402485-5592-4D71-8A52-6317E775C0C6

Q37878617-A21A2742-14FA-4D9F-B138-CE30B26B63B3

Q37878617-DB7F3D85-8DFE-47AC-A99F-046E67F52A69

Q37878617-F5AC2C2E-0A33-4CCB-AA4E-96C22D29CADF

P2860

Q37878617-004BA10B-228B-4D0C-ACB4-99E4C9E5B80A

Q37878617-06AE39AA-D943-4591-A192-8B4E1E9C286C

Q37878617-1AA2AEB8-A342-4653-B7E9-A9C6DB2C41D3

Q37878617-27B74D89-5BE4-49F8-91C8-1EC57532E20B

Q37878617-2EB9BD34-D844-4A1A-B3F5-57FDB3060CD4

Q37878617-320D0AC7-10A4-4B5A-AB9E-15C295A5220A

Q37878617-33A247F1-6860-4C0E-9988-B07E6660EF8B

Q37878617-347C468E-6F54-402B-BA49-158C2DAB9838

Q37878617-3D3AC18D-C0E8-4735-A24E-BA82B5A83BEC

Q37878617-3EE77C33-BBF7-40BE-8732-46F167B1F341

P304

Q37878617-E2AFE3B3-E376-4720-9BCB-9BBF21302085

P31

Q37878617-8C5EF78C-DCA1-414B-92EB-1598E6EDD1E5

P356

Q37878617-FAF3E8CA-92DC-4BCC-BCAE-03FB392BD1C6

P407

Q37878617-E7ADFAAB-E827-41C1-AE85-698D83A630BC

P433

Q37878617-56739D18-E2BC-425C-A035-A8F69C46E43F

P478

Q37878617-89BC9072-3EEB-4E1D-8D8F-864A49DFFD87

P577

Q37878617-384E4E85-FD91-4BD6-952B-91892B982F56

P5875

Q37878617-16F38744-8624-4568-BB56-E04E4D7680D4

P698

Q37878617-8F9F7A4C-0D93-4245-AA70-A65E243C2A6C

P932

Q37878617-DA0B37FB-B8E4-45A7-99C7-545E82F3551C

P356

BMJ.318.7190.1035

P1433

P1476

Relation of Chlamydia pneumoni ...... ospective heart disease study.

@en

P2093

B K Butland

http://www.w3.org/2001/XMLSchema#string

D Carrington

http://www.w3.org/2001/XMLSchema#string

D P Strachan

http://www.w3.org/2001/XMLSchema#string

J Morris

http://www.w3.org/2001/XMLSchema#string

L Ballam

http://www.w3.org/2001/XMLSchema#string

M A Mendall

http://www.w3.org/2001/XMLSchema#string

P C Elwood

http://www.w3.org/2001/XMLSchema#string

P M Sweetnam

http://www.w3.org/2001/XMLSchema#string

P2860

Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group

Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study

Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.

Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis

Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study.

Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene.

Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression.

P304

1035-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.318.7190.1035

http://www.w3.org/2001/XMLSchema#string

P407

P433

7190

http://www.w3.org/2001/XMLSchema#string

P478

318

http://www.w3.org/2001/XMLSchema#string

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232263645

http://www.w3.org/2001/XMLSchema#string

P698

10205100

http://www.w3.org/2001/XMLSchema#string

P932

27832

http://www.w3.org/2001/XMLSchema#string